17454455

Bhathena RK

2007

Therapeutic options in the polycystic ovary syndrome.

17455042

Pehlivanov B

2007

Efficacy of an oral contraceptive containing drospirenone in the treatment of women with polycystic ovary syndrome.

17456573

Tan BK

2007

Raised serum, adipocyte, and adipose tissue retinol-binding protein 4 in overweight women with polycystic ovary syndrome: effects of gonadal and adrenal steroids.

17458313

Murakami H

2006

[Metabolic syndrome associated with polycystic ovary syndrome].

17459387

Sun L

2007

Three-dimensional transrectal ultrasonography in adolescent patients with polycystic ovarian syndrome.

17460501

Triantafyllopoulou M

2007

Hepatic adenoma in an adolescent with elevated androgen levels.

17462639

Engmann L

2008

The use of gonadotropin-releasing hormone (GnRH) agonist to induce oocyte maturation after cotreatment with GnRH antagonist in high-risk patients undergoing in vitro fertilization prevents the risk of ovarian hyperstimulation syndrome: a prospective randomized controlled study.

17462641

Shroff R

2007

Risk of metabolic complications in the new PCOS phenotypes based on the Rotterdam criteria.

17462645

Ingudomnukul E

2007

Elevated rates of testosterone-related disorders in women with autism spectrum conditions.

17465332

Engler D

2007

Hypothesis: Musculin is a hormone secreted by skeletal muscle, the body's largest endocrine organ. Evidence for actions on the endocrine pancreas to restrain the beta-cell mass and to inhibit insulin secretion and on the hypothalamus to co-ordinate the neuroendocrine and appetite responses to exercise.

17465999

Demirel F

2007

Serum leptin, oxidized low density lipoprotein and plasma asymmetric dimethylarginine levels and their relationship with dyslipidaemia in adolescent girls with polycystic ovary syndrome.

17468256

Sir-Petermann T

2007

Serum adiponectin and lipid concentrations in pregnant women with polycystic ovary syndrome.

17470712

Perciaccante A

2007

Polycystic ovary syndrome: androgens, autonomic nervous system, and hypertension.

17471299

Bruns CM

2007

Prenatal androgen excess negatively impacts body fat distribution in a nonhuman primate model of polycystic ovary syndrome.

17471581

Ozkan S

2007

Color Doppler sonographic analysis of uterine and ovarian artery blood flow in women with polycystic ovary syndrome.

17472015

Draveck? I

2007

[Epilepsy and disorders of reproduction].

17474189

Vokaer R

1973

[The enigmatic Stein-Leventhal syndrome].

17474205

Vitse M

1973

[The obstetrical future of micropolycystic ovaries].

17474660

Paldi E

1973

[Surgical culdoscopy in cases of sterilization and of polycystic ovary syndrome].

17484627

Vrbikova J

2007

Prevalence of insulin resistance and prediction of glucose intolerance and type 2 diabetes mellitus in women with polycystic ovary syndrome.

17485308

Zhao H

2007

Orphan nuclear receptor function in the ovary.

17488788

Crisosto N

2007

Anti-M?llerian hormone levels in peripubertal daughters of women with polycystic ovary syndrome.

17488794

Stanek MB

2007

Insulin and insulin-like growth factor stimulation of vascular endothelial growth factor production by luteinized granulosa cells: comparison between polycystic ovarian syndrome (PCOS) and non-PCOS women.

17489164

Orbetsova M

2006

[Effect of 6-month treatment with oral antiandrogen alone and in combination with insulin sensitizers on body composition, hormonal and metabolic parameters in women with polycystic ovary syndrome (PCOS) in order to determine therapeutic strategy].

17489165

Pekhlivanov B

2006

[Determinants of health related quality of life in women with polycystic ovary syndrome].

17489169

Robeva R

2006

[The anti-mullerian hormone--physiology and application into clinical practice].

17489756

Godinjak Z

2007

Clinical outcome and hormone profiles before and after laparoscopic electroincision of the ovaries in women with polycystic ovary syndrome.

17489777

Velija-Asimi Z

2007

C-reactive protein in obese PCOS women and the effect of metformin therapy.

17494937

Panidis D

2007

Treatment of infertility in the polycystic ovary syndrome.

17495003

Manner?s L

2007

A new rat model exhibiting both ovarian and metabolic characteristics of polycystic ovary syndrome.

17495209

Moeller R

2007

Evaluation of risk profiles by subcutaneous adipose tissue topography in obese juveniles.

17495382

Vignesh JP

2007

Polycystic ovary syndrome: a component of metabolic syndrome?

17496361

Evans JL

2007

Antioxidants: do they have a role in the treatment of insulin resistance?

17502881

Pesant MH

2007

Ovulation induction in polycystic ovary syndrome-how do metformin and clomifene citrate compare?

17504892

Moran LJ

2007

C-reactive protein before and after weight loss in overweight women with and without polycystic ovary syndrome.

17505944

Nawrocka J

2007

Effects of metformin treatment in women with polycystic ovary syndrome depends on insulin resistance.

17506158

Geberhiwot T

2007

Treatment of infertility in the polycystic ovary syndrome.

17506159

Bell DS

2007

Treatment of infertility in the polycystic ovary syndrome.

17509189

Lim JH

2007

New alternative to infertility treatment for women without ovarian stimulation.

17509201

Kadoch IJ

2007

Controlled natural cycle IVF: a novel approach for a dominant follicle during an in-vitro maturation cycle.

17509385

Folli F

2007

Metabolic aspects of bariatric surgery.

17509393

Patel JA

2007

Improvement in infertility and pregnancy outcomes after weight loss surgery.

17509728

Galletly C

2007

Psychological benefits of a high-protein, low-carbohydrate diet in obese women with polycystic ovary syndrome--a pilot study.

17512308

Xita N

2007

The adiponectin-to-leptin ratio in women with polycystic ovary syndrome: relation to insulin resistance and proinflammatory markers.

17513319

Hyun CS

2007

Optimal ICSI timing after the first polar body extrusion in in vitro matured human oocytes.

17515888

Nader S

2007

Ovulation induction in women with polycystic ovary syndrome.

17515889

Balen AH

2007

Is metformin the treatment of choice for anovulation in polycystic ovary syndrome?

17516292

Cupisti S

2007

Evaluation of biochemical hyperandrogenemia and body mass index in women presenting with amenorrhea.

17517397

Grossman MP

2008

M?llerian-inhibiting substance inhibits cytochrome P450 aromatase activity in human granulosa lutein cell culture.

17519312

Palomba S

2007

Insulin sensitivity after metformin suspension in normal-weight women with polycystic ovary syndrome.

17520407

Haller K

2007

VNTR I/I genotype of insulin gene is associated with the increase of follicle number independent from polycystic ovary syndrome.

17524347

Cortet-Rudelli C

2007

Etiological diagnosis of hyperprolactinemia.

17524398

Ge HS

2008

Exposure to human chorionic gonadotropin during in vitro maturation does not improve the maturation rate and developmental potential of immature oocytes from patients with polycystic ovary syndrome.

17525068

Hendriks ML

2007

Effect of laparoscopic ovarian diathermy on circulating inhibin B in women with anovulatory polycystic ovary syndrome.

17526620

Mahajan NN

2007

Sonographic evaluation of the endometrium in patients with a history or an appearance of polycystic ovarian syndrome.

17526940

Weiping L

2006

Elevated serum RBP4 is associated with insulin resistance in women with polycystic ovary syndrome.

17535842

Feig DS

2007

Oral antidiabetic agents in pregnancy and lactation: a paradigm shift?

17535988

Salih S

2007

Lower levels of urinary 2-hydroxyestrogens in polycystic ovary syndrome.

17536071

Luque-Ram?rez M

2007

Increased body iron stores of obese women with polycystic ovary syndrome are a consequence of insulin resistance and hyperinsulinism and are not a result of reduced menstrual losses.

17537782

Barnard L

2007

Quality of life and psychological well being in polycystic ovary syndrome.

17540511

Torre A

2007

[Polycystic ovary syndrome (PCOS)].

17541663

Subramanian S

2007

Practice patterns of screening for sleep apnea in physicians treating PCOS patients.

17543254

Pillai A

2007

Metformin and glitazones: do they really help PCOS patients?

17543961

Soares EM

2008

Prevalence of the metabolic syndrome and its components in Brazilian women with polycystic ovary syndrome.

17547089

Galindo Garc?a CG

2007

[Mechanism of action of insulin sensitizer agents in the treatment of polycystic ovarian syndrome].

17548076

Kj?tr?d SB

2008

C-reactive protein levels are unaffected by metformin during pretreatment and an IVF cycle in women with polycystic ovary syndrome.

17550210

B?y?kgebiz A

2007

Hirsutism in adolescent girls.

17550211

Siklar Z

2007

Functional ovarian hyperandrogenism and polycystic ovary syndrome in prepubertal girls with obesity and/or premature pubarche.

17557764

Ma X

2007

Proteomic analysis of human ovaries from normal and polycystic ovarian syndrome.

17558680

Palomba S

2007

What is the best first-step therapeutic approach in treating anovulatory infertility in patients with polycystic ovary syndrome? Questions that are still unanswered.

17558682

Lee SH

2007

A patient with combined polycystic ovary syndrome and autoimmune polyglandular syndrome type 2.

17558684

Filho RB

2007

Polycystic ovary syndrome and hyperprolactinemia are distinct entities.

17558685

Marcondes JA

2007

Metformin in normal-weight hirsute women with polycystic ovary syndrome with normal insulin sensitivity.

17559842

Seifer DB

2007

Mullerian Inhibiting Substance is an ovarian growth factor of emerging clinical significance.

17559844

Baillargeon JP

2007

Role of insulin in the hyperandrogenemia of lean women with polycystic ovary syndrome and normal insulin sensitivity.

17560682

Cerda C

2007

Nonalcoholic fatty liver disease in women with polycystic ovary syndrome.

17561004

Vizer M

2007

Assessment of three-dimensional sonographic features of polycystic ovaries after laparoscopic ovarian electrocautery.

17562334

Carmina E

2008

Subcutaneous and omental fat expression of adiponectin and leptin in women with polycystic ovary syndrome.

17562338

Zhao S

2007

Discovery of distinct protein profiles for polycystic ovary syndrome with and without insulin resistance by surface-enhanced laser adsorption/ionization time of flight mass spectrometry.

17563058

Skov V

2007

Reduced expression of nuclear-encoded genes involved in mitochondrial oxidative metabolism in skeletal muscle of insulin-resistant women with polycystic ovary syndrome.

17564892

Vyjayanthi S

2007

Modern trends in ovulation induction.

17565837

Hu WH

2007

[Association of monocyte chemoattractant protein-1 and the clinical characteristics of polycystic ovary syndrome: analysis of 65 cases].

17566093

Calaf J

2007

Long-term efficacy and tolerability of flutamide combined with oral contraception in moderate to severe hirsutism: a 12-month, double-blind, parallel clinical trial.

17568874

Martins AB

2007

Physiopathology of obstructive sleep apnea-hypopnea syndrome.

17570095

Lehnert H

2007

[Endocrinology 2007].

17570263

Toscani M

2007

Estimation of truncal adiposity using waist circumference or the sum of trunk skinfolds: a pilot study for insulin resistance screening in hirsute patients with or without polycystic ovary syndrome.

17573242

Kalinin VV

2007

Chronology and evolution of temporal lobe epilepsy and endocrine reproductive dysfunction in women: relationships to side of focus and catameniality.

17575082

Eng GS

2007

AMP kinase activation increases glucose uptake, decreases apoptosis, and improves pregnancy outcome in embryos exposed to high IGF-I concentrations.

17576851

Armanini D

2007

Polycystic ovary syndrome: implications of corticotropin in the regulation of blood pressure, aldosterone, and androgen secretion.

17578583

Avery JC

2007

The information needs of women diagnosed with Polycystic Ovarian Syndrome--implications for treatment and health outcomes.

17579224

Willenberg HS

2007

Polycystic ovary syndrome and infertility.

17579978

Nargund G

2007

Low-dose HCG is useful in preventing OHSS in high-risk women without adversely affecting the outcome of IVF cycles.

17582143

Kowalska I

2007

Serum visfatin in relation to insulin resistance and markers of hyperandrogenism in lean and obese women with polycystic ovary syndrome.

17582406

Badawy A

2009

Clomiphene citrate or letrozole for ovulation induction in women with polycystic ovarian syndrome: a prospective randomized trial.

17583175

Cho LW

2007

Cardiometabolic aspects of polycystic ovarian syndrome.

17583237

Nardo LG

2007

Ultrasonography in polycystic ovary syndrome: an update.

17583494

Petry CJ

2007

Lack of association between common polymorphisms in the 17beta-hydroxysteroid dehydrogenase type V gene (HSD17B5) and precocious pubarche.

17583701

Mattle V

2008

Polycystic ovarian disease unmasked by pulsatile GnRH therapy in a subgroup of women with hypothalamic amenorrhea.

17587857

Escobar ME

2007

Acceleration of luteinizing hormone pulse frequency in adolescent girls with a history of central precocious puberty with versus without hyperandrogenism.

17587858

Rosenfield RL

2007

Does a primary acceleration of LH pulse frequency underlie an association between central precocious puberty and polycystic ovary syndrome? Commentary on Escobar ME et al: Acceleration of LH pulse frequency in adolescent girls with a history of central precocious puberty with versus without hyperandrogenism (Horm Res 2007;68:278-285).